A Phase I, First-in-Human clinical trial of AB 101 (Insulin) in subjects with type 1 diabetes mellitus.

Trial Profile

A Phase I, First-in-Human clinical trial of AB 101 (Insulin) in subjects with type 1 diabetes mellitus.

Recruiting
Phase of Trial: Phase I

Latest Information Update: 25 Jul 2017

At a glance

  • Drugs Insulin (Primary)
  • Indications Type 1 diabetes mellitus
  • Focus Adverse reactions; First in man
  • Sponsors AntriaBio
  • Most Recent Events

    • 25 Jul 2017 According to an AntriaBio media release, Following the completion of the first part of the study, the company expects to review data and announce high-level results as early as Q4 2017.
    • 25 Jul 2017 According to an AntriaBio media release, first patient has been dosed.
    • 25 Jul 2017 Status changed from planning to recruiting according to an AntriaBio media release.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top